Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua J Gagne

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Drug Safety|September 5, 2014
Restrictive reimbursement policies: bias implications for claims-based drug safety studiesJoshua J Gagne
Epidemiology (Cambridge, Mass.)|August 2, 2013
You can observe a lot (about medical products) by watching (those who use them)Joshua J Gagne
Drug Safety|June 20, 2015
Common Models, Different ApproachesJoshua J Gagne
JAMA Internal Medicine|October 21, 2014
Finding meaningful patterns in adverse drug event reportsJoshua J Gagne
Pharmacoepidemiology and Drug Safety|February 22, 2017
New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approachJoshua J Gagne
Pharmacoepidemiology and Drug Safety|June 10, 2016
Balancing benefits and harms: privacy protection policiesAmeet Sarpatwari, Joshua J Gagne
Statistics in Medicine|February 16, 2013
Comment on 'empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership'Joshua J Gagne, Sebastian Schneeweiss
JAMA|July 5, 2022
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-ReplyKatsiaryna Bykov, Joshua J Gagne
The Annals of Pharmacotherapy|March 6, 2009
Comment: pharmaceutical care for migraine and headache patients: a community-based, randomized interventionJoshua J Gagne, Vittorio Maio
Clinical Pharmacology and Therapeutics|October 23, 2019
Response to "The Self-Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions"Katsiaryna Bykov, Joshua J Gagne
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Drug Safety|September 5, 2014
Restrictive reimbursement policies: bias implications for claims-based drug safety studiesJoshua J Gagne
Epidemiology (Cambridge, Mass.)|August 2, 2013
You can observe a lot (about medical products) by watching (those who use them)Joshua J Gagne
Drug Safety|June 20, 2015
Common Models, Different ApproachesJoshua J Gagne
JAMA Internal Medicine|October 21, 2014
Finding meaningful patterns in adverse drug event reportsJoshua J Gagne
Pharmacoepidemiology and Drug Safety|February 22, 2017
New-user designs with conditional propensity scores: a unified complement to the traditional active comparator new-user approachJoshua J Gagne
Pharmacoepidemiology and Drug Safety|June 10, 2016
Balancing benefits and harms: privacy protection policiesAmeet Sarpatwari, Joshua J Gagne
Statistics in Medicine|February 16, 2013
Comment on 'empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership'Joshua J Gagne, Sebastian Schneeweiss
JAMA|July 5, 2022
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-ReplyKatsiaryna Bykov, Joshua J Gagne
The Annals of Pharmacotherapy|March 6, 2009
Comment: pharmaceutical care for migraine and headache patients: a community-based, randomized interventionJoshua J Gagne, Vittorio Maio
Clinical Pharmacology and Therapeutics|October 23, 2019
Response to "The Self-Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions"Katsiaryna Bykov, Joshua J Gagne
Pageof 25